Skip to content
10-K

Annual Report

ABEONA THERAPEUTICS INC. ABEO

0001493152-26-010413

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 11, 2026 57.05M sh
Shares Diluted FY 2025 · Dec 31, 2025 66.14M sh
Shares Diluted FY 2025 · Dec 31, 2024 41.05M sh
Capex FY 2025 · Dec 31, 2025 $7.98M
Capex FY 2025 · Dec 31, 2024 $2.45M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$76.33M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$56.02M
Long Term Debt FY 2025 · Dec 31, 2025 $7.81M
Long Term Debt FY 2025 · Dec 31, 2024 $13.04M
Short Term Investments FY 2025 · Dec 31, 2025 $112.97M
Short Term Investments FY 2025 · Dec 31, 2024 $74.36M
Cash And Equivalents FY 2025 · Dec 31, 2025 $78.44M
Cash And Equivalents FY 2025 · Dec 31, 2024 $23.36M
Stockholders Equity FY 2025 · Dec 31, 2025 $159.22M
Stockholders Equity FY 2025 · Dec 31, 2024 $44.03M
Stockholders Equity FY 2025 · Dec 31, 2023 $14.83M
Current Liabilities FY 2025 · Dec 31, 2025 $29.57M
Current Liabilities FY 2025 · Dec 31, 2024 $16.59M
Total Liabilities FY 2025 · Dec 31, 2025 $60.35M
Total Liabilities FY 2025 · Dec 31, 2024 $64.9M
Current Assets FY 2025 · Dec 31, 2025 $204.91M
Current Assets FY 2025 · Dec 31, 2024 $100.85M
Total Assets FY 2025 · Dec 31, 2025 $219.57M
Total Assets FY 2025 · Dec 31, 2024 $108.93M
Eps Diluted FY 2025 · Dec 31, 2025 $1.01
Eps Diluted FY 2025 · Dec 31, 2024 −$1.55
Eps Basic FY 2025 · Dec 31, 2025 $1.34
Eps Basic FY 2025 · Dec 31, 2024 −$1.55
Sga Expense FY 2025 · Dec 31, 2025 $65.03M
Sga Expense FY 2025 · Dec 31, 2024 $29.85M
Rd Expense FY 2025 · Dec 31, 2025 $26.81M
Rd Expense FY 2025 · Dec 31, 2024 $34.36M
Net Income FY 2025 · Dec 31, 2025 $71.18M
Net Income FY 2025 · Dec 31, 2024 −$63.73M
Operating Income FY 2025 · Dec 31, 2025 −$89.45M
Operating Income FY 2025 · Dec 31, 2024 −$64.21M
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.53M
Revenue FY 2025 · Dec 31, 2025 $5.82M